[Norovirus infections in Germany].
Noroviruses are responsible for the majority of acute viral gastroenteritis infections worldwide. Transmission may be faecal-oral or through contaminated food and water or airborne by virus-containing aerosols. Characteristics of noroviruses that facilitate their spread are their high concentration in stool and vomitus, their extreme environmental stability, their low infectious dose as well as the lack of long-lasting immunity. The majority of norovirus infections occur in large outbreaks among persons living in institutional settings, such as hospitals and nursing homes, although sporadic cases also occur. Children and elderly persons are most often affected. Illness is characterized by acute onset of projectile vomiting. For prevention and control of norovirus outbreaks strict control management is necessary. Based on the high genomic variability new variant noroviruses with different pathogenic factors can arise. Depending on the circulating variant the extent of the usual winter peak can vary enormously. Available diagnostic methods include RT-PCR assays for detection of viral RNA, electron microscopy and enzyme immunoassays (EIA) for detection of viral antigens. The implicated virus can be subtyped through nucleotide sequencing and linked to a specific outbreak. With the enactment of the Protection against Infection Act in January 2001 a mandatory reporting system of norovirus infections was established. Analysis of surveillance data from this system permits a detailed overview of the nationwide epidemiology of this disease in Germany.
Koch
J
J
Robert Koch-Institut, Berlin. kochj@rki.de
Schneider
T
T
Stark
K
K
Schreier
E
E
D017250:Caliciviridae Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D005759:Gastroenteritis / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D029322:Norovirus / Q000302:isolation & purification*; D011159:Population Surveillance / Q000379:methods; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors